LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy.

Nagaja CapitaniGiulia LoriPaolo PaoliLaura PatrussiArianna TroiloCosima T BaldariGiovanni RaugeiMario Milco D'Elios

Published in: Cancer cell international (2019)

Morin treatment in CLL-derived Mec-1 cell line synergizes with conventional anticancer drugs currently used in CLL therapy by affecting leukemic cell viability and trafficking.

Keyphrases

chronic lymphocytic leukemia
acute myeloid leukemia
mesenchymal stem cells
bone marrow
combination therapy